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Dear Editor,
We report a case of sleep terror in a 4-year-old boy, patient A. 
The parents observed that for the past month, after the patient 
going bed to sleep, A. have being wake up in the middle of the 
night. This behavior occurs once or twice a week. On these 
occasions, the child is found standing somewhere in the house, 
crying and seemingly disoriented with rapid breathing and 
profuse sweating. When the parents attempt to comfort him or 
return him to his room, he becomes quite upset, striking out at 
them and screaming loudly. He continues to scream and fight 
for several minutes, followed by spontaneous cessation. Once 
the child is calmed, the parents can put him back in his bed, 
and he sleeps through the rest of the night without incident. In 
the morning, he wakes up in usual happy mood and does not 
remember what occurred the previous evening. The parents are 
worried that the might be having seizures or developing a severe 
behavioral problem. Lab blood work-up is solicited, including an 
electroencephalogram (EEG). All returned normal results.
Arousal parasomnias (night terrors, sleepwalking, and 
confusional arousals) have seldom been investigated in the adult 
general population. Clinical studies of parasomnias, however, 
show that these disorders may be indicators of underlying mental 
disorders and may have serious consequences. Prevalence rates 
are based on self-reported data and, consequently, are likely 
underestimated.1,2
Night terror and somnambulism tend to occur during periods 
of arousal from delta sleep. As a result, these disorders are more 
common in children who have more delta sleep and they often 
occur during the first half of the night when there is more delta 
sleep occurring. Patient who sleepwalks often shows amnesia 
to the event on awakening as well.2
Generally, pharmacologic or extensive behavioral treatment 
should not be considered prior to age 7. The treatment of sleep 
terror disorder usually consists of reassuring the parent that, with 
time, the child will outgrow these harmless events. Nocturnal 
enuresis might be involved with night terror event.1-3 Our patient 
A also presented about one year ago a history of enuresis that was 
successfully treated by imipramine. However, the recommended 
treatment for sleep terror disorder is to assure the parents that 
their child will probably grow out of this developmental, but 
in this case we chose a selective serotonin reuptake inhibitor 
antidepressant – fluoxetine 20 mg per day, for 2 months, 
achieving good response after 6 weeks treatment.4
This patient’s presentation is typical for sleep terror, a disorder 
that found in 3% of all children and less than 1% of adults. 
Typically, sleep terror manifests itself as emotional an behavioral 
disturbances at night. This disorder is usually time–limited.4,5
These findings suggest that specific factors, perhaps reflecting 
an interaction of lifestyle and hereditary contributions, may be 
responsible for the observed variability in this condition.4 More 
research to clarify the underlying physiopathology of this disorder 
is important to define the differential diagnosis and test the 
efficacy of different treatment.
Dear Editor,
People with schizophrenia have a two to three-fold increased 
risk to die prematurely than those without schizophrenia and this 
excess of mortality is accounted for by a combination of increased 
risk factors such as patients’ life style, suicide (in particular 
in young male patients soon af ter diagnosis), premature 
development of cardiovascular disease, high prevalence of 
metabolic syndrome, carbohydrate and lipid metabolic disorders 
and equally important but not so often mentioned is sudden 
unexpected death.1 The exact pathophysiological ca use of 
sudden unexpected death in schizophrenia (SUDS) is unknown, 
but it is probable that cardiac arrhythmia plays a potential role.2
Because cardiac abnormalities are an important cause in sudden 
death we discuss whether it is possible that winter temperatures 
may facilitate cardiac abnormalities and hence SUDS. Exposure 
to winter temperatures is considered to be one of the main 
factors influencing morbidity and mortality from cardiovascular 
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diseases, including sudden death.3 Therefore, it is interesting 
to review some findings3 that explain an increase in cardiac 
events to cold temperatures: there is 53% more cases of acute 
myocardial infarction reported during the winter compared with 
the summer. During the winter, increases in hemoconcentration 
(erythrocyte count, plasma cholesterol and plasma fibrinogen 
levels) have been reported, which could contribute to arterial 
thrombosis. Cold weather can induce a higher systemic vascular 
resistance with an increase in the blood pressure (thus increasing 
oxygen demand). Winter temperatures may be associated with 
flu season and an increase in upper respiratory tract infections 
could place stress on the heart. According to these lines of 
evidence, we believe that cold weather could also be considered 
a new potential risk factor of sudden cardiac death in patients 
with schizophrenia. 
At the moment, there is no information in the literature 
that describes the relationship between winter temperatures 
and SUDS. In accordance with this reasoning, we are totally 
in agreement with Davidson’s perspectives:4 “Because the 
modifiable risk factors for coronary atherosclerosis and sudden 
death are so prevalent within the schizophrenic population, it 
is important for clinicians treating patients with schizophrenia 
to know what these risks are and understand how they can 
contribute to increased mortality in these patients”.
In the mean time, some actions (medical or non-medical 
therapies) may help to prevent SUDS. For that, Kloner5 has 
described some very interesting commonsense and prudent 
tactics that the physician should consider during the winter 
time (called “Merry Christmas Coronary” and “Happy New Year 
Heart Attack”), especially for patients with established cardiac 
disease or for those with known risk factors for cardiac disease: 
1) Instruct patients to avoid delay in seeking medical attention, 
should cardiac symptoms occur; 2) Instruct patients to avoid the 
known triggers for acute myocardial infarction, as excess physical 
exertion (especially shoveling snow), overeating, lack of sleep, 
emotional stress, illegal drugs, and anger. Avoid excess salt and 
alcohol intake. (Alcohol can also precipitate arrhythmias such as 
atrial fibrillation – the “holiday heart syndrome” and can depress 
cardiac contractility; 3) Modify and treat known cardiovascular 
risk factors (e.g., hypertension, smoking, diabetes, dyslipidemia); 
4) Consider aspirin or B-blockers, or both, if appropriate; 5) 
Instruct patients to avoid exposure to severely cold temperatures; 
6) Consider flu shots where appropriate.
Finally, the next logical steps to us, neuroscientists, are 
to understand and associate the mechanisms by which cold 
weather could influence the cardiovascular system of patients 
with schizophrenia. These mechanisms are likely to be important 
for developing new strategies in the prevention of SUDS. 
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Com menos hospitais psiquiátricos, 
morrem mais portadores de 
transtornos mentais no Brasil?
Are more persons with mental disorders 
dying due to fewer mental hospitals in 
Brazil?
Sr. Editor,
Na edição de 9 de dezembro de 2007, o jornal O Globo 
publicou a reportagem “Sem hospícios, morrem mais doentes 
mentais”, que apresentou a informação de que o “número de 
mortes de doentes mentais e comportamentais” aumentara 41% 
entre 2001 e 2006 (respectivamente, 6.655 e 9.398 mortes) 
no Brasil, mencionando que “[n]o mesmo período, um quarto 
dos leitos psiquiátricos do país foi fechado, sem que fossem 
criados serviços substitutos suficientes”.1 Será que a ilação 
proposta pela matéria é cientificamente consistente? Proponho 
aqui analisarmos brevemente se os dados apresentados podem 
sustentar que o fechamento substancial de leitos psiquiátricos no 
país estaria associado a um acréscimo nas mortes de portadores 
de transtornos mentais (TM).
Já de início se percebe um erro grave na interpretação dos 
dados, que não dizem respeito à mortalidade geral de portadores 
de TM, mas sim à mortalidade específica por TM – comparável 
a se confundir a morte de anêmicos com a morte por anemia. 
Verificando na Tabela 1 os registros de mortalidade específica 
do Sistema de Informações sobre Mortalidade (SIM), disponíveis 
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